SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-21-000068
Filing Date
2021-11-12
Accepted
2021-11-12 07:04:16
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20210930.htm   iXBRL 10-Q 2004169
2 EX-31.1 ex311_angnx09302021-10q.htm EX-31.1 10578
3 EX-31.2 ex312_angnx09302021-10q.htm EX-31.2 10024
4 EX-32.1 ex321angn-09302021x10q.htm EX-32.1 6121
5 EX-32.2 ex322_angnx09302021-10q.htm EX-32.2 6182
  Complete submission text file 0001601485-21-000068.txt   8599796

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20210930.xsd EX-101.SCH 61013
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20210930_cal.xml EX-101.CAL 81995
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20210930_def.xml EX-101.DEF 322881
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20210930_lab.xml EX-101.LAB 732242
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20210930_pre.xml EX-101.PRE 490618
11 EXTRACTED XBRL INSTANCE DOCUMENT angn-20210930_htm.xml XML 1327707
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 211399489
SIC: 2834 Pharmaceutical Preparations